Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms

• Belkys C. Sanchez,
• Emmaline R. Heckmann,
• Sabrina I. Green,
• Justin R. Clark,
• Heidi B. Kaplan,
• Robert F. Ramig,
• Kenneth L. Muldrew,
• Kenneth L. Muldrew,
• Kenneth L. Muldrew,
• Casey Hines-Munson,
• Felicia Skelton,
• Felicia Skelton,
• Barbara W. Trautner,
• Barbara W. Trautner,
• Barbara W. Trautner,
• Anthony W. Maresso

Affiliations

Belkys C. Sanchez

Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States

Emmaline R. Heckmann

Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States

Sabrina I. Green

Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States

Justin R. Clark

Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States

Heidi B. Kaplan

Department of Microbiology and Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX, United States

Robert F. Ramig

Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States

Kenneth L. Muldrew

Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States

Kenneth L. Muldrew

Pathology and Laboratory Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, United States

Kenneth L. Muldrew

Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, United States

Casey Hines-Munson

Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States

Felicia Skelton

Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States

Felicia Skelton

H. Ben Taub Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, United States

Barbara W. Trautner

Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, United States

Barbara W. Trautner

Department of Medicine and Surgery, Baylor College of Medicine, Houston, TX, United States

Barbara W. Trautner

Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, United States

Anthony W. Maresso

Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States